U.S. Therapeutic Monoclonal Antibodies Markets

 


The U.S. Therapeutic Monoclonal Antibodies Markets is a evolving market undergoing many changes. This research service includes in depth analysis of the total market as well as the various therapeutic classes for which monoclonal antibodies are available. This analysis includes revenue forecasts, product/pipeline analysis, and strategic perspectives of the market. A number of strategic recommendations to be successful are provided in the research service.

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Therapeutic Monoclonal Antibodies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Therapeutic Monoclonal Antibodies Markets, Objectives and Scope Objectives and ScopeObjectivesScopeU.S. Therapeutic Monoclonal Antibodies Markets, Introduction to Monoclonal AntibodiesMonoclonal Antibodies Market OverviewIntroductionStructure of AntibodiesTypical Problems with Murine mAbsThe Role of Hybridoma CloneMedical Utility of mAbsMarket OverviewEvolution and Technology TrendsIntroductionEarly Murine mAbsChimeric mAbsHumanized mAbsFully Human mAbsPhage Display of Human mAbsMonoclonal Antibodies as CarriersNaked Monoclonal AntibodiesConjugated Monoclonal AntibodiesFuture of Monoclonal AntibodiesThe Foundation for Optimistic FutureReturn on Investment and FutureU.S. Therapeutic Monoclonal Antibodies Markets, Industry ChallengesChallenges Affecting the US Therapeutic Monoclonal Antibodies MarketIntroductionIncreasing Costs and Complexities of Clinical TrialsLong-Term Safety and EfficacyHigh Cost of mAbsRestricted Government Healthcare SpendingComplexities of Registration ProcessesProduction Capacity CrunchIdentify New Targets or Access Validated TargetsSmall Molecule DrugsSecond Line to First Line TherapyProduction Challenges of Humanized and Human mAbs U.S. Therapeutic Monoclonal Antibodies Markets, Pipeline AnalysisOverview of the mAbs PipelineIntroductionTherapeutic mAbs in OncologyTherapeutic mAbs in Autoimmune and Inflammatory DisordersTherapeutic mAbs in Organ TransplantsTherapeutic mAbs in Cardiovascular DisordersTherapeutic mAbs in Infectious DiseasesTherapeutic mAbs in Miscellaneous IndicationsParticipants in mAB Development and/or MarketingU.S. Therapeutic Monoclonal Antibodies Markets, Total US Therapeutic Monoclonal Antibodies MarketMarket DynamicsIntroductionMarket Engineering MeasurementMarket DriversMarket RestraintsMarket ForecastsForecast AssumptionsTotal Revenue ForecastsSegment-wise Revenue ForecastsIssue of Pricing and ReimbursementsFrost and Sullivan AwardsTechnology Excellence AwardEntrepreneurial Company AwardCompetitive Strategy Leadership AwardGrowth Strategy Leadership AwardIndustry Innovation and Advancement AwardTechnology Innovation AwardU.S. Therapeutic Monoclonal Antibodies Markets, Competitive AnalysisCompetitive StructureCompetitive FactorsCompanies in Therapeutic mAbs ResearchCompanies in Marketing and Sales of Therapeutic mAbsThe Dynamism of DealsMarket Share AnalysisU.S. Therapeutic Monoclonal Antibodies Markets, US Therapeutic Monoclonal Antibodies for Use in OncologyOverviewIntroductionMarket Engineering MeasurementMarket ForecastsRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisCompetitive FactorsU.S. Therapeutic Monoclonal Antibodies Markets, US Therapeutic Monoclonal Antibodies in Autoimmune and Inflammatory DisordersOverviewIntroductionMarket Engineering MeasurementMarket ForecastsRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisCompetitive FactorsU.S. Therapeutic Monoclonal Antibodies Markets, US Therapeutic Monoclonal Antibodies for Use in Organ TransplantsOverviewIntroductionMarket Engineering MeasurementMarket ForecastsRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Therapeutic Monoclonal Antibodies Markets, US Therapeutic Monoclonal Antibodies for Use in Cardiovascular DisordersOverviewIntroductionMarket Engineering MeasurementMarket ForecastsRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Therapeutic Monoclonal Antibodies Markets, US Therapeutic Monoclonal Antibodies for Use in Infectious Diseases OverviewIntroductionMarket Engineering MeasurementMarket ForecastsRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisMarket Engineering Strategy for the US Therapeutic Monoclonal Antibodies MarketStrategic RecommendationsIntroductionMarket Life CycleSkills Required to be Successful - Strengths PyramidSeven Ways to GrowthStrategies for Success for mAb Industry ParticipantsU.S. Therapeutic Monoclonal Antibodies Markets, Decision Support DatabasesOncology DatabasesProstate CancerBreast CancerBladder CancerColon Rectum CancerLung CancerStomach CancerLiver CancerAutoimmune and Inflammatory Disorders DatabasesArthritisMultiple SclerosisOrgan Transplant DatabasesMajor Organ TransplantsHeart TransplantsKidney TransplantsPancreas TransplantsLiver TransplantsLung TransplantsCardiovascular DatabasesCardiologistsHypertensionStrokeMyocardial Infarction




Related Research

Release Date : 18-Aug-17

Region : North America

Release Date : 17-Aug-17

Region : North America

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.